Correlation Between Reviva Pharmaceuticals and Nautilus Biotechnology
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Nautilus Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Nautilus Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Nautilus Biotechnology, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Nautilus Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Nautilus Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Nautilus Biotechnology.
Diversification Opportunities for Reviva Pharmaceuticals and Nautilus Biotechnology
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Reviva and Nautilus is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Nautilus Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nautilus Biotechnology and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Nautilus Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nautilus Biotechnology has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Nautilus Biotechnology go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Nautilus Biotechnology
Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to generate 1.73 times more return on investment than Nautilus Biotechnology. However, Reviva Pharmaceuticals is 1.73 times more volatile than Nautilus Biotechnology. It trades about 0.02 of its potential returns per unit of risk. Nautilus Biotechnology is currently generating about 0.0 per unit of risk. If you would invest 414.00 in Reviva Pharmaceuticals Holdings on September 12, 2024 and sell it today you would lose (162.00) from holding Reviva Pharmaceuticals Holdings or give up 39.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Nautilus Biotechnology
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Nautilus Biotechnology |
Reviva Pharmaceuticals and Nautilus Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Nautilus Biotechnology
The main advantage of trading using opposite Reviva Pharmaceuticals and Nautilus Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Nautilus Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nautilus Biotechnology will offset losses from the drop in Nautilus Biotechnology's long position.| Reviva Pharmaceuticals vs. Protalix Biotherapeutics | Reviva Pharmaceuticals vs. Eyepoint Pharmaceuticals | Reviva Pharmaceuticals vs. Sellas Life Sciences | Reviva Pharmaceuticals vs. In8bio Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |